iNtRON产品代理

产品分类 > 科研试剂 > iNtRON产品代理

iNtRON产品代理

以“全球R&BD集团”为目标
Intron Bio 正在为 (1) 人类受试者和 (2) 疾病治疗药物开发新药。
(3)以First-in-Class(MoA_based)的方向和目标,
以成为不局限于单纯的研究,以业务发展为目标的“全球R&BD集团”为目标,
以及不断投资建设多个新的生物制药管道,
我们正在逐步将(L/O)技术转移到国内外市场,用于各种新药管道。
通过这种方式,我们将逐步提升我们作为一家新型生物制药公司的价值。
价格: 0.00

Aiming for   "Global R&BD Group"

Intron Bio   is developing new drugs for (1) human subjects and (2) disease treatment   drugs.

(3) With the   direction and goal of First-in-Class (MoA_based),

Aiming to   become a “global R&BD group” that is not limited to simple research but aims for business   development,

As well as   continuously investing in building a number of new biopharmaceutical   pipelines,

We are   gradually transferring (L/O) technology to domestic and overseas markets for   various new drug pipelines.

   

Through this, we will gradually increase our value as a new biopharmaceutical company.